InMed Pharmaceuticals

INMNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.636 M

$1.39 +0.72%

Close of 22 Sept 2026

Revenue

$4.94M

#3285 by revenue

Earnings

-$8.16M

Loss-making

Shares outstanding

3,314,063

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#446Traws PharmaTRAW$7.68M
#447CNS PharmaceuticalsCNSP$7.66M
#448InMed PharmaceuticalsINM$7.64M
#449Skye BioscienceSKYE$7.57M
#450Acurx PharmaceuticalsACXP$7.56M

What if InMed Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$5,503,354

Per share 3,959,247× higher

Bitcoin $1.74T

$317,025.66

Per share 228,076× higher

Nvidia $5.52T

$1,004,010

Per share 722,310× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for InMed Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.